Brawn Biotech has informed that a meeting of the Board of Directors of the company was held today 18th June 2020, have considered, approved and taken on record the Standalone Audited Financial Results of Brawn Biotech for the fourth quarter and financial year ended March 31st 2020, which was recommended by the Audit Committee at their meeting held on 18 June 2020. Further, pursuant to provisions of Regulation 33 of SEBI Listing Regulations, it has enclosed Standalone Audited Financial Results, along with Auditor’s Report and declaration on unmodified Audit report. Further informed that the meeting of the Board of Directors commenced at 12:30 PM and concluded at 2:30 PM.
The above information is a part of company’s filings submitted to BSE.
